Abstract

BackgroundAlthough radiation therapy (RT) improves local control for rectal cancer (RC), the long-term risks from RT, including development of a secondary malignancy, are controversial. The risk and prognosis of secondary bladder cancer (SBC) in RC patients undergoing RT have not been adequately studied. Our goal is to investigate the impact of RT on the risk of developing SBC and assess their survival outcomes.MethodsThis large population-based study included RC patients as their initial primary cancer from nine registries of the Surveillance, Epidemiology and End Results (SEER) database between 1973 and 2015. The cumulative incidence of SBC was assessed by using Fine and Gray’s competing risk regression. The standardized incidence ratio (SIR) was used to compare the incidence of SBC in RC survivors to the US general population. The Kaplan-Meier method was used to evaluate the 10-year overall survival (OS) and 10-year cancer specific survival (CSS) for patients with SBC.ResultsOf 74,646 RC patients, 24,522 patients were treated with surgery and RT and 50,124 patients were treated with surgery alone. The incidence of SBC was 1.85% among patients who received RT and 1.24% among patients who did not. The incidence of SBC in RC patients who received RT was higher than the US general population (SIR, 1.35; 95% CI, 1.19-1.53, P<0.05), and decreased with increasing age at diagnosis, and increased with time since diagnosis. In competing risk regression analysis, undergoing RT was associated with a higher risk of SBC (hazard ratio [HR], 1.443, 95% confidence interval [CI], 1.209-1.720; P<0.001). The results of the dynamic SIR for SBC revealed that a slightly increased risk of SBC was observed after RT in the early latency, and was significantly related to the variations of age at RC diagnosis and decreased with time progress. The 10-year OS and CSS among SBC patients after RT were comparable to SBC patients after NRT.ConclusionRadiation was associated with an increased risk of developing SBC in RC patients, and special attention should be paid to the surveillance of these patients.

Highlights

  • Total mesorectal excision and adjuvant radiation therapy (RT) has been considered as the standard treatment regimen for locally advanced rectal cancer (RC), with superior local control when compared with surgery alone [1, 2]

  • Of 74,646 RC patients, 24,522 patients were treated with surgery and RT and 50,124 patients were treated with surgery alone

  • The incidence of secondary bladder cancer (SBC) in RC patients who received RT was higher than the US general population (SIR, 1.35; 95% confidence intervals (CIs), 1.19-1.53, P

Read more

Summary

Introduction

Total mesorectal excision and (neo) adjuvant radiation therapy (RT) has been considered as the standard treatment regimen for locally advanced rectal cancer (RC), with superior local control when compared with surgery alone [1, 2]. Risk factors for the development of SPC are multifactorial, including normal aging, genetic predisposition, environmental and lifestyle risk factors, and treatment for initial primary cancer [5, 7, 8]. Some of these risk factors could be partially avoidable, through methods such as adopting a healthy lifestyle and getting appropriate cancer treatment. Radiation therapy (RT) improves local control for rectal cancer (RC), the long-term risks from RT, including development of a secondary malignancy, are controversial. Our goal is to investigate the impact of RT on the risk of developing SBC and assess their survival outcomes

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call